$98 Million

Rocket Pharmaceuticals

Follow-on Offering

Bookrunner, December 2019

Rocket Pharmaceuticals
Rocket Pharmaceuticals, Inc. is a clinical stage biotechnology company focused on developing gene therapy treatment options for rare, devastating diseases.